New data suggest that the investigational antiviral drug remdesivir may interact with chloroquine phosphate or hydroxychloroquine sulfate and concurrent use of these agents is not recommended for the management of patients with COVID-19.
Maria G. Tanzi, PharmDMaria G. Tanzi, PharmD